Clinical Trial Update: Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing the acute safety, deliverability, and efficacy of the Medtronic Resolute Integrity zotarolimus-eluting coronary stent in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriosclerosis
• Cardiovascular Disease
• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Resolute Integrity Zotarolimus-Eluting Coronary Stent System (Zotarolimus-eluting coronary stent system)

Snippet

Sponsor: Medtronic Vascular | Conditions: Ischemic Heart Disease, Cardiovascular Diseases | Phase 3 | Status: COMPLETED